Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 5/20 | 0.51 |
| ▸ | MMP9 | P14780 | 5/20 | 0.51 |
| ▸ | MMP8 | P22894 | 5/20 | 0.51 |
| ▸ | MMP13 | P45452 | 5/20 | 0.51 |
| ▸ | PSMD10 | O75832 | 1/20 | 0.45 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.41 |
| ▸ | TUBB | P07437 | 1/20 | 0.41 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.41 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.41 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.41 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.41 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.41 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.41 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.41 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.41 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.41 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.41 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.41 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.41 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14924261 | 0.88 | MMP2 (0.49) | MMP2MMP9MMP8MMP13PSMD10 | |
| SCHEMBL14043068 | 0.75 | MMP2 (0.46) | MMP2MMP9MMP8MMP13PSMD10 | |
| SCHEMBL943760 | 0.75 | CA12 (0.51) | MMP2MMP9MMP8MMP13PSMD10 | |
| SCHEMBL941807 | 0.74 | MMP2 (0.43) | MMP2MMP9MMP8MMP13PSMD10 | |
| SCHEMBL16511356 | 0.72 | PSMD10 (0.51) | MMP2MMP9MMP8MMP13PSMD10 | |
| SCHEMBL16510904 | 0.72 | PSMD10 (0.49) | MMP2MMP9MMP8MMP13PSMD10 | |
| SCHEMBL14219017 | 0.72 | ALDH1A1 (0.47) | MMP2MMP9MMP8MMP13PSMD10 | |
| SCHEMBL6647468 | 0.70 | CA1 (0.41) | MMP2MMP9MMP8MMP13PSMD10 | |
| SCHEMBL4592604 | 0.70 | MMP2 (0.39) | MMP2MMP9MMP8MMP13PSMD10 | |
| SCHEMBL17032632 | 0.69 | MMP2 (0.40) | MMP2MMP9MMP8MMP13PSMD10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130116206-A1 | QUINOLINE DERIVATIVES USED AS PET IMAGING AGENTS | IMPERIAL INNOVATIONS LIMITED (GB) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130116206-A1 | QUINOLINE DERIVATIVES USED AS PET IMAGING AGENTS | ERBB2, EGFR, ERBB4 | MMP2 2099/4885MMP9 3871/4885MMP8 3612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.